ALEXUS P LUDWIG

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Epilepsy BUFFALO, NY NPI 1124581558

General Payments — all program years on this page

$1,495.23

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,356.37 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $963.8119
Travel and Lodging $392.562

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
LivaNova USA, Inc. $982.2410
NEUROPACE, INC. $137.491
UCB, Inc. $108.625
EISAI INC. $57.472
SK Life Science, Inc. $29.671
REVANCE THERAPEUTICS, INC. $24.281
Neurelis, Inc. $16.601

By program year

Program yearAmountRecords
2023 $138.865
2024 $1,356.3721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110727895 Eisai Inc. $25.82 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110727897 Eisai Inc. $31.65 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143084659 UCB, Inc. $17.37 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143084661 UCB, Inc. $24.27 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143084663 UCB, Inc. $15.76 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143084665 UCB, Inc. $28.58 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143084667 UCB, Inc. $22.64 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145647058 Neurelis, Inc. $16.60 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147923418 REVANCE THERAPEUTICS, INC. $24.28 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790025 LivaNova USA, Inc. $18.69 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790031 LivaNova USA, Inc. $22.96 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790053 LivaNova USA, Inc. $3.88 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790069 LivaNova USA, Inc. $12.39 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790077 LivaNova USA, Inc. $18.40 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790099 LivaNova USA, Inc. $6.48 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790101 LivaNova USA, Inc. $3.19 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790117 LivaNova USA, Inc. $297.95 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1152790119 LivaNova USA, Inc. $503.69 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152790121 LivaNova USA, Inc. $94.61 09/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1153273472 NEUROPACE, INC. $137.49 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154130835 SK Life Science, Inc. $29.67 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.